Dr. Khavari's experimental focus is on the mammalian setting, including mouse genetics, human genetics and new human tissue platforms.

Dr. Bassik's lab studies how endocytic pathogens such as bacterial toxins, viruses, and protein aggregates enter the cell, disrupt homeostasis, and cause apoptosis.

Dr. Barsh's laboratory is interested in the mechanisms that give rise to eye, hair, and skin coloration, both as a tool for studying gene action and interaction, and because many signaling pathways used by the pigmentary system play important roles in human development and disease.

Dr. Bayati has two main research interests: machine learning and statistical models for large data, and their applications in healthcare.

Research areas in the Bao Group include synthesis of functional organic and polymer materials, organic electronic device design and fabrication, and applications development for organic electronics.

Dr. Kenny's group is researching fundamental issues and applications of micromechanical structures.

Dr. Banaei's current research interests include development and implementation of rapid diagnostic assays for the detection, identification, and susceptibility testing of clinically important mycobacteria and uderstanding the role of M. tuberculosis lipoproteins in the pathogenesis of tuberculosis.

Dr. Bambos's current technology research interests include high-performance networking, autonomic computing, and service engineering.

The Baker lab's main focus is to understand the signals necessary for patterning and specifying diverse cellular fates during gastrulation in the mouse.

Dr. Kay's goal for the Program in Human Gene Therapy is to develop gene transfer technologies and use them for hepatic gene therapy for the treatment of genetic and acquired diseases.